Note: Ingredients listed on restricted chemical lists
EC/CAS
55965-84-9
Name of the chemical
3(2H)-Isothiazolone, 5-chloro-2-methyl-, mixt. with 2-methyl-3(2H)-isothiazolone
Concentration
>=0,0025-< >=0,6% 0,06-<0,6% 0,06-<0,6% >=0,0015% >=0,6%
General Information
Revision date
2022-02-17
Product name
beta-Microglobulin
Emergency telephone
+49(0)621-759-2203, +49(0)6131-19240
Icons in SDS
Company Information
company name
Roche Diagnostics Deutschland GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info.dia-sds@roche.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects.
Precautionary statements
P261 Avoid breathing mist or vapours. P273 Avoid release to the environment. P280 Wear protective gloves.
Response
P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
55965-84-9 reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2- methyl-2H-isothiazol-3-one (3:1)
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Long-term (chronic) aquatic hazard, H412: Harmful to aquatic life with long lasting Category 3 effects. 2.2 Label elements Labelling (REGULATION (EC) No 1272/2008) Hazard pictograms : Signal word : Warning Hazard statements : H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects. Prevention: Precautionary statements : P261 Avoid breathing mist or vapours. P273 Avoid release to the environment. P280 Wear protective gloves. Response: P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse. Disposal: P501 Dispose of contents/ container to an approved waste disposal plant. Hazardous components which must be listed on the label: 55965-84-9 reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2- methyl-2H-isothiazol-3-one (3:1) 2.3 Other hazards This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Ecological information: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Toxicological information: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. SECTION 3: Composition/information on ingredients
